Navigation Links
Aurobindo Pharma Purchases US Manufacturing Facility

The Hyderabad-based Aurobindo Pharma Ltd today said it has acquired a USFDA compliant manufacturing facility in Dayton, New Jersey//.

The facility, spread over 20 acres of freehold land, will serve as the company's US head quarters, it informed the stock exchanges.

"This purchase reinforces Aurobindo's commitment to serve US market in an effective manner," Ramprasad Reddy, Chairman of the company, said.

The campus comprises 100,000 square feet of fully integrated state of the art R&D, formulation manufacturing and distribution facilities with potential for future expansion, it said.

The company is located in the heart of Princeton Life Sciences Corridor in the state of New Jersey.

The Company has recently concluded zero per cent, foreign currency convertible bonds issue USD 200 million (Rs 900 crore). Part of the proceeds will be used for the purchase, it added.

The shares of the company closed at Rs 577.70, down 2.18 percent on the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Aurobindo gets U.S. FDA approval for Cephalexin
2. US FDA approved Aurobindo Pharma to produce generic AIDS drug
3. Aurobindo Receives Approval from USFDA for anti-AIDS drug
4. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
5. Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets
6. Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack
7. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
8. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
9. Pharma cos must forge Strategic alliances
10. Medicis Pharmaceutical company enters pediatric market
11. Pharma majors gear to supply anti-anthrax drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Lice Troopers, ... lice cases in families with school-aged children since the holiday season. , “It ... holidays with their families, sharing hugs and taking photos, which is the head-to-head gateway ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
(Date:1/20/2017)... ... ... Biscuit”: a biographical account following a man who went on to support his country and ... born in Lynn Haven, Florida and at the age of 5, his family moved to ... joined the Navy and got married right out of boot camp. , He and ...
(Date:1/20/2017)... ... ... enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is the ... devoted woman of faith. , “Becoming a parent changes you. In my case, the ... years, but actually doing it might have been a while in coming if it hadn’t ...
(Date:1/19/2017)... ... 20, 2017 , ... Today, the Centers for Medicare & Medicaid Services (CMS) ... Payment Models (APMs) in 2017. Clinicians who participate in APMs are paid for the ... of the Administration’s effort to build a system that delivers better care and one ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Accuray Incorporated ... CyberKnife® and TomoTherapy® Systems continue to set the bar ... the highest composite overall user satisfaction rating among radiation ... Q4 2016 MD Buyline Market Intelligence Briefing™. The most ... highest composite ratings among industry peers for 11 of ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. (Nasdaq: ... federal institution supporting research in Germany ... patient treatments at the University Clinic Heidelberg as part ... The MRIdian Linac program will be headed by Medical ... heads radiation oncology at the German Cancer Research Center ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology: